Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.87 |
| ▸ | LMNA | P02545 | 4/20 | 0.87 |
| ▸ | MEN1 | O00255 | 4/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.87 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.87 |
| ▸ | HTT | P42858 | 2/20 | 0.87 |
| ▸ | MAPT | P10636 | 2/20 | 0.87 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.87 |
| ▸ | GAA | P10253 | 1/20 | 0.87 |
| ▸ | TSHR | P16473 | 2/20 | 0.75 |
| ▸ | NPC1 | O15118 | 2/20 | 0.75 |
| ▸ | RAB9A | P51151 | 2/20 | 0.75 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | PPARA | Q07869 | 3/20 | 0.63 |
| ▸ | PPARG | P37231 | 1/20 | 0.63 |
| ▸ | PPARD | Q03181 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17857331 | 0.89 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11593471 | 0.88 | ALDH1A1 (0.85) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11594572 | 0.88 | ALDH1A1 (0.85) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL23832195 | 0.87 | ALDH1A1 (0.83) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25548814 | 0.87 | ALDH1A1 (0.83) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL28224427 | 0.86 | ALDH1A1 (0.82) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL21793229 | 0.84 | ALDH1A1 (0.77) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30001190 | 0.84 | ALDH1A1 (0.77) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL28069114 | 0.83 | ALDH1A1 (0.76) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22435156 | 0.83 | ALDH1A1 (0.75) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986582-A | Bio-based high-toughness self-repairing flexible resin and preparation method thereof | 江南大学 | 2024-05-07 | — | — | CN | claimed |
| CN-116096787-B | Co-modified organopolysiloxane and use thereof | 陶氏东丽株式会社 | 2024-10-18 | — | — | CN | disclosed |
| CN-117986582-A | Bio-based high-toughness self-repairing flexible resin and preparation method thereof | 江南大学 | 2024-05-07 | — | — | CN | disclosed |
| US-20230331924-A1 | CO-MODIFIED ORGANOPOLYSILOXANE AND USE THEREOF | DOW TORAY CO., LTD. (JP) | 2023-10-19 | — | — | US | disclosed |
| EP-4219596-A1 | CO-MODIFIED ORGANOPOLYSILOXANE AND USE THEREOF | Dow Toray Co., Ltd. (JP) | 2023-08-02 | — | — | EP | disclosed |
| CN-116096787-A | Co-modified organopolysiloxane and use thereof | 陶氏东丽株式会社 | 2023-05-09 | — | — | CN | disclosed |
| WO-2022065520-A1 | CO-MODIFIED ORGANOPOLYSILOXANE AND USE THEREOF | ダウ・東レ株式会社 | 2022-03-31 | — | — | WO | disclosed |
| CN-105189430-B | High-purity glycerol derivatives containing monoene and its manufacturing method | 道康宁东丽株式会社 | 2018-08-10 | — | — | CN | disclosed |
| CN-104136498-B | Novel liquid organopolysiloxanes and use thereof | 道康宁东丽株式会社 | 2017-06-20 | — | — | CN | disclosed |
| CN-104136499-B | Novel co-modified organopolysiloxane, and treatment agent and external preparation comprising the same | 道康宁东丽株式会社 | 2017-06-06 | — | — | CN | disclosed |
| CN-103619915-B | List or the derivative modified organopolysiloxane elastomers of Glycerol dimer and utilization thereof | DOW CORNING TORAY CO.,LTD. (JP) | 2015-12-23 | — | — | CN | disclosed |
| CN-103619915-A | Organopolysiloxane elastomer modified with mono-/diglycerin derivative, and use therefor | DOW CORNING TORAY CO LTD | 2014-03-05 | — | — | CN | disclosed |
| CN-103619916-A | Novel organopolysiloxane elastomers and their use | DOW CORNING TORAY CO LTD | 2014-03-05 | — | — | CN | disclosed |
| US-4474963-A | PHASE TRANSFER CATALYSTS | W. R. GRACE & CO. (US) | 1984-10-02 | — | — | US | disclosed |
| US-3975324-A | VULCANIZABLE POLYURETHANE ELASTOMER | AMERICAN CYANAMID COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331924-A1 | CO-MODIFIED ORGANOPOLYSILOXANE AND USE THEREOF | MGLL, LIPA, DAGLB | ALDH1A1 2086/4885LMNA 337/4885MEN1 1339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.